Aetna Unveils 2026 Medicare Advantage Plans with Expanded Benefits
Aetna announces its 2026 Medicare Advantage plans featuring expanded supplemental benefits, enhanced Special Needs Plans, and affordable prescription drug coverage across 43 states.
Aetna announces its 2026 Medicare Advantage plans featuring expanded supplemental benefits, enhanced Special Needs Plans, and affordable prescription drug coverage across 43 states.
Humana’s 2026 Medicare Advantage and Prescription Drug Plans emphasize simplicity, stability, and expanded access, with lowered premiums and enhanced benefits for Medicare beneficiaries nationwide.
TruChoice Financial Group launches SmartHub, an integrated platform streamlining annuity sales for financial professionals with enhanced order management and compliance.
The DOJ sues Inland Empire Health Plan for allegedly misusing $320 million in federal Medicaid surplus funds, highlighting compliance challenges in managed care programs.
Explore why Texas car insurance rates are among the highest in the U.S., driven by risk factors, uninsured drivers, and regulatory challenges impacting premiums.
Ambetter from Centene is refunding over $1 billion to Missouri health insurance policyholders for underspending on care under ACA Medical Loss Ratio rules, reshaping the state's individual insurance market.
USAA to pay $5 million to settle Maryland class-action lawsuit alleging unlawful late fees on auto insurance policies. Settlement pending court approval.
SelectQuote Inc. faces a DOJ whistleblower lawsuit over Medicare Advantage sales practices, triggering stock declines and investor class-action suits. Key updates on regulatory compliance and market impact.
CVS Health's Aetna expands nurse-led program to reduce hospital readmissions among Medicare Advantage members, aligning with CMS readmission penalties effective 2027. Program enhances care coordination and post-discharge support in key U.S. hospitals.
Examination of Q2 earnings for U.S. health insurers reveals growth trends, regulatory challenges, and economic factors shaping market performance in 2024.